Patients with moderate to severe psoriasis associate with higher risk of depression and anxiety symptoms: results of a multivariate study of 300 spanish individuals with psoriasis
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Tribó Boixareu, María José
- dc.contributor.author Turroja, Marta
- dc.contributor.author Castaño Vinyals, Gemma
- dc.contributor.author Bulbena Vilarrasa, Antonio
- dc.contributor.author Ros, Elena
- dc.contributor.author García-Martínez, Pablo
- dc.contributor.author Tausk, Francisco
- dc.contributor.author Sagristà, Marc
- dc.contributor.author Pujol Vallverdú, Ramon Maria
- dc.contributor.author Ferran Farrés, Marta
- dc.contributor.author Gallardo Hernández, Fernando
- dc.date.accessioned 2019-10-31T08:39:14Z
- dc.date.available 2019-10-31T08:39:14Z
- dc.date.issued 2019
- dc.description.abstract Psoriasis is a chronic skin disease associated with considerable physical and psychological comorbidities. Stress and emotional disturbances have been implicated in both triggering the onset and exacerbation of psoriasis. In order to determine the level of perceived stress and mood alterations in patients with psoriasis and their association with disease severity, 300 individuals completed diverse validated questionnaires assessing stress and psychological mood. Evaluation of perception of disease was also measured. A significant association between psoriasis severity and mood, emotional disturbances and an impact on assessments of the quality of life were observed. Particularly, Montgomery-Asberg Depression Rating Scale, Hamilton Rating Scale and Hospital Anxiety and Depression Scale for Depression detected a significant risk for depression in relation to the disease severity. The association between depression features, anxiety and perceived stress with psoriasis severity is important and can influence the appropriate management of psoriasis.
- dc.format.mimetype application/pdf
- dc.identifier.citation Tribó MJ, Turroja M, Castaño-Vinyals G, Bulbena A, Ros E, García-Martínez P et al. Patients with moderate to severe psoriasis associate with higher risk of depression and anxiety symptoms: results of a multivariate study of 300 spanish individuals with psoriasis. Acta Derm Venereol. 2019 Apr 1;99(4):417-22. DOI: 10.2340/00015555-3114
- dc.identifier.doi http://dx.doi.org/10.2340/00015555-3114
- dc.identifier.issn 0001-5555
- dc.identifier.uri http://hdl.handle.net/10230/42570
- dc.language.iso eng
- dc.publisher Society for Publication of Acta Dermato-Venereologica
- dc.relation.ispartof Acta Dermato-Venereologica. 2019 Apr 1;99(4):417-22
- dc.rights All articles are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. https://creativecommons.org/licenses/by-nc/4.0/
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri https://creativecommons.org/licenses/by-nc/4.0/
- dc.subject.keyword Anxiety
- dc.subject.keyword Depression
- dc.subject.keyword Mood
- dc.subject.keyword Psoriasis
- dc.subject.keyword Quality of life
- dc.subject.keyword Stress
- dc.title Patients with moderate to severe psoriasis associate with higher risk of depression and anxiety symptoms: results of a multivariate study of 300 spanish individuals with psoriasis
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion